Oral nystatin prophylaxis and neonatal fungal infections

Oral nystatin prophylaxis and neonatal fungal infections

Background:The value of antifungal prophylaxis depends partly on the incidence of neonatal fungal infection. We compared the incidence of fungal infection in babies in neonatal units which do and do not give antifungal prophylaxis using oral nystatin.Methods:Prospective, multi-centre surveillance st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of disease in childhood. Fetal and neonatal edition 2009-11, Vol.94 (6), p.F429-F433
Hauptverfasser: Howell, A, Isaacs, D, Halliday, R, Infections, The Australasian Study Group for Neonatal
Format: Artikel
Sprache:eng
Schlagworte:
Antifungal Agents - therapeutic use
Australia - epidemiology
Babies
Birth weight
Candidiasis - epidemiology
Candidiasis - prevention & control
Children & youth
Fungal infections
Humans
Incidence
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases - epidemiology
Infant, Premature, Diseases - microbiology
Infant, Premature, Diseases - prevention & control
Infant, Very Low Birth Weight
Intensive Care Units, Neonatal
Intensive Care, Neonatal
Meningitis
New Zealand - epidemiology
Nystatin - therapeutic use
Prophylaxis
Prospective Studies
Studies
Surveillance
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background:The value of antifungal prophylaxis depends partly on the incidence of neonatal fungal infection. We compared the incidence of fungal infection in babies in neonatal units which do and do not give antifungal prophylaxis using oral nystatin.Methods:Prospective, multi-centre surveillance study from 1993 to 2006 of invasive fungal infection, defined as positive blood or cerebrospinal fluid culture, in babies
ISSN:1359-2998
1468-2052
DOI:10.1136/adc.2008.157123